You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
15 June 2026 - Inhibrx Biosciences Inc (Nasdaq: INBX) disclosed on Monday that it has received U.S. Food and Drug Administration acceptance of its Biologics License Application for ozekibart (INBRX-109) for the treatment of patients with unresectable...
15 June 2026 - Clinical-stage biotechnology company Sensei Biotherapeutics Inc (Nasdaq:SNSE) announced on Monday that it has changed its corporate name to Faeth Therapeutics Inc, with its common stock expected to begin trading under the ticker symbol...
15 June 2026 - German pharmaceutical and life sciences company Bayer AG (ETR:BAYN) (OTC:BAYRY) said on Monday that it has received US Food and Drug Administration (FDA) approval for AMBELVIST (gadoquatrane), an intravenous macrocyclic gadolinium-base...
15 June 2026 - Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced on Friday positive top-line efficacy results from its completed Phase 2a PROHEAR Study.ACOU...
15 June 2026 - The Menarini Group, an Italy-based international pharmaceutical and diagnostics company, and Stemline Therapeutics Inc, a subsidiary of the Menarini Group focused on oncology treatments, announced on Sunday the presentation of new data...